Kostaive self-amplifying mRNA in New Zealand
John Armstrong made this Official Information request to Pharmaceutical Management Agency
This request has an unknown status. We're waiting for John Armstrong to read recent responses and update the status.
From: John Armstrong
Dear Pharmaceutical Management Agency,
I seek information for Kostaive self-amplifying mRNA as listed on pg 10, section 8 - Market Analysis, in a prior response received from Pharmac, reference H2025072586, Procurement Plan for Covid-19 vaccine RFP.
https://fyi.org.nz/request/32255-supply-...
It states: "Pharmac staff are aware of four Covid-19 vaccines that may be available in New Zealand". These were then listed as follows:
1/ Kostaive (Seqirus) self-amplifying mRNA.
2/ Spikevax (Moderna) mRNA
3/ Comirnaty (Pfizer) mRNA
4/ Nuvaxovid (Biocelect /Novavax) attenuated protein subunit
Q1/ Is Kostaive currently in circulation and being administered in NZ?
Q2/ Has Kostaive been administered in the past in NZ, please provide dates?
Q3/ Please supply documentation of clinical trials for Kostaive in NZ?
Q4/ Please supply Medsafe's approval and consent for distribution of Kostaive in NZ.
Yours faithfully,
John Armstrong
From: Web Enquiry
Pharmaceutical Management Agency
Thank you for contacting Pharmac, we have received your enquiry and will
endeavour to have a reply to you as soon as we can.
Pharmac cannot provide medical advice. If you have questions about your
health or are experiencing side effects from medicines, please call:
· Your usual healthcare provider.
· Healthline on 0800 611 116.
· 111 for medical emergencies.
This e-mail message and any accompanying attachments may contain
confidential information. If you are not the intended recipient, please do
not read, use, disseminate, distribute or copy this message or
attachments. If you have received this message in error, please notify the
sender immediately and delete this message.
From: John Armstrong
Dear Pharmaceutical Management Agency,
Thank you for your response received via email on the 11th November 2025. However, the response does not reflect in this FYI thread. In the interests of transparency to any potential public viewers can you please post your response here.
In addition can Pharmac please supply an updated response explaining how you answered "No" when your own documentation states:
"Pharmac staff are aware of four Covid-19 vaccines that may be available in
New Zealand" as witnessed in as listed on pg 10, section 8 -
Market Analysis, in a prior response received from Pharmac, reference
H2025072586.
Yours faithfully,
John Armstrong
From: Ministerial
Pharmaceutical Management Agency
Kia ora John
Thank you for your request for official information, which Pharmac received on 25 November 2025. The reference number for your request is: 2025-26-108
You should receive a response from us on or before 23 December 2025. This is within the 20 working day limit set out in the Official Information Act.
Please contact us if you have any questions.
Ngā mihi,
Government Services | Pharmac
show quoted sections
From: Ministerial
Pharmaceutical Management Agency
Ministerial would like to recall the message, "F-2571 Re: Official Information request - Kostaive self-amplifying mRNA in New Zealand".
This e-mail message and any accompanying attachments may contain confidential information. If you are not the intended recipient, please do not read, use, disseminate, distribute or copy this message or attachments. If you have received this message in error, please notify the sender immediately and delete this message.
From: Ministerial
Pharmaceutical Management Agency
Kia ora John
Thank you for your request for official information, which Pharmac received on 25 November 2025. The reference number for your request is: 2025-26-108
You should receive a response from us on or before 23 December 2025. This is within the 20 working day limit set out in the Official Information Act.
Please contact us if you have any questions.
Ngā mihi,
Government Services | Pharmac
show quoted sections
Things to do with this request
- Add an annotation (to help the requester or others)
- Download a zip file of all correspondence (note: this contains the same information already available above).

